Research Networks and Grants
FNUSA-ICRC is a member of several European research networks:
- CZECRIN/ECRIN: Czech national network for academic clinical trials / part of the European ECRIN network
- EATRIS: European infrastructure for translational medicine
- ELIXIR: a distributed infrastructure for life-science information
- ESO-EAST: East European program of the European Stroke Organization
- European Sleep Apnoea Database
- HBM4EU: European human biomonitoring initiative
- RES-Q: registry of stroke care quality of the European Stroke Organisation
Horizon 2020 Grants
FNUSA-ICRC is proud to have participated in more than 10 Horizon 2020 grants and has a fast-increasing number of research grants from many sources, such as the Horizon 2020 program, INTERREG, EU Structural Funds, Grant Agency of the Czech Republic, Technology Agency of the Czech Republic, Agency for Healthcare Research, Czech Ministry of Education, or from the South Moravian Region.
We are actively seeking further H2020 opportunities and would be interested to join emerging H2020 consortia which are planning to apply for grants in fields of our research.
Should you wish to explore the possibility to apply for a joint grant with us, please contact Head of the Grant Support Center (petr.rychtecky(at)fnusa.cz).
Alliance4Life is a strategic project of ten research institutions from nine Central and Eastern European countries. The project aims to highlight current gaps in health research and to reduce the gap between the innovative performance of new and original members of the European Union.official website
Our Center is honored to be the project coordinator of the Project "Molecular, Cell and Clinical Approach to Healthy Aging (abbreviated ENOCH)" from the Operational Program Research, Development and Education, administered by the Ministry of Education, Youth and Sports of the Czech Republic.
The main research objective of the project is to formulate a joint research program that is focused on research into aging and age-related diseases, namely cancer, chronic inflammation and degenerative diseases during the implementation project phase from 2018 to 2023. Thanks to this project unifying five major research institutions in the Moravian Region (Institute of Molecular and Translation Medicine at Palackého University in Olomouc - IMTM, the Regional Center of Applied Molecular Oncology of the Masaryk Oncological Institute - RECAMO, the Department of Neurology at the Faculty of Medicine, Olomouc University Hospital and the Blood Cancer Research Group at Ostrava University – BCRG), a unique platform for top scientists in Moravia will be created.